The impact of obesity on urological disorder
Keywords:
Urological disorder, Obesity, UrologyAbstract
The global obesity epidemic is chief among these trends in modern medical discourse. Data from the National Center for Health Statistics estimate that 39.8% of U.S. adults aged 20 years and over were obese in the year 2015 to 2016.[1] Urology is a surgical discipline that spans a variety of anatomical and metabolic systems, and is constantly influenced by global health trends in both subtle and apparent ways.
Obesity, defined as a body mass index ≥ 30 kg/m2 in adults by the National Institutes of Health, is associated with an increased risk for a number of health conditions, including hypertension, unfavorable lipid level, and diabetes mellitus.
More recently, there has been greater interest in the effects of obesity on a variety of benign and malignant urologic conditions. Obesity has been shown to have an effect on urolithiasis; benign prostatic hyperplasia and lower urinary tract symptoms; female incontinence, overactive bladder and pelvic prolapse; male hypogonadism; and male sexual function and infertility. These urologic diseases have a considerable impact on patients' quality of life.
Furthermore, dietary or lifestyle modification and other public health measures directed at reducing weight may reduce the incidence of urologic illnesses. More studies are necessary to determine the therapeutic effects of weight loss and dietary modification on the incidence and progression of benign and malignant urologic conditions.
References
Hales CM, Carroll MD, Fryar CD, et. al. Prevalence of obesity among adults and youth: United States, 2015–2016. NCHS Data Brief. 2017;228:1.
Taylor EN, Stampfer MJ, and Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005;293: 455.
Ekeruo WO, Tan YH, Young MD, et. al. Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. J Urol. 2004;172:159.
Powell CR, Stoller ML, Schwartz BF, et. al. Impact of body weight on urinary electrolytes in urinary stone formers. J Urol. 2000;55: 825.
Wollin DA, Skolarikos AA, and Preminger GM. Obesity and metabolic stone disease. Curr Opin Urol. 2017;27: 422.
Sinha MK, Collazo-Clavell ML, Rule A, et. al. Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Int. 2007;72: 100.
Thomas R, and Cass AS. Extracorporeal shock wave lithotripsy in morbidly obese patients. J Urol. 1993;150: 30.
Natalin R, Xavier K, Okeke Z, et. al. Impact of obesity on ureteroscopic laser lithotripsy of urinary tract calculi. Int Braz J Urol. 2009;35: 36.
Riedner CE, Rhoden EL, Ribeiro EP, et. al. Central obesity is an independent predictor of erectile dysfunction in older men. J Urol. 2006;176: 1519.
Esposito K, Giugliano F, Di Palo C, et. al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA. 2004;291: 2978.
Diaz-Arjonilla M, Schwarcz M, Swerdloff RS, et. al. Obesity, lower testosterone levels and erectile dysfunction. Int J Impot Res. 2009;21: 89.
Sallmén M, Sandler DP, and Hoppin JA. Reduced fertility among overweight and obese men. Epidemiology. 2006;17:520.
Luboshitzky R, Lavie L, Shen-Orr Z, et. al. Altered luteinizing hormone and testosterone secretion in middle-aged obese men with obstructive sleep apnea. Obes Res. 2005;13: 780.
Caprio M, Isidori AM, and Carta AR. Expression of functional leptin receptors in rodent Leydig cells. Endocrinology. 1999;140: 4939.
Martins AD, Moreira AC, Sa R, et. al. Leptin modulates human Sertoli cells acetate production and glycolytic profile: a novel mechanism of obesity-induced male infertility? Biochim Biophys Acta. 2015;1852: 1824.
Pasquali R, Patton L, and Gambineri A. Obesity and infertility. Curr Opin Endocrinol Diabetes Obes. 2007;14: 482.
Ho CK, and Habib FK. Estrogen and androgen signaling in the pathogenesis of BPH. Nat Rev Urol. 2011;8: 29.
Ozden C, Ozdal OL, Urgancioglu G, et. al. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia. Eur Urol. 2006;51: 199.
Mydlo JH, Michaeli J, Heston WD, et. al. Expression of basic fibroblast growth factor mRNA in benign prostatic hyperplasia and prostatic carcinoma. Prostate. 1988;13: 241.
Fowke JH, Koyama T, Fadare O, et. al. Does inflammation mediate the obesity and BPH relationship? An epidemiologic analysis of body composition and inflammatory markers in blood, urine, and prostate tissue, and the relationship with prostate enlargement and lower urinary tract symptoms. PLoS One. 2016;11: e0156918.
Nickel JC. Role of prostatic inflammation in the clinical presentation of benign prostatic hyperplasia. Eur Urol, suppl. 2015;14: e1459.
Jung JH, Ahn SV, Song JM, et. al. Obesity as a risk factor for prostatic enlargement: a retrospective cohort study in Korea. Int Neurourol J. 2016;20: 321.
Wing RR, West DS, Grady D et al: Effect of weight loss on urinary incontinence in overweight and obese women: results at 12 and 18 months. J Urol. 2010;184: 1005.
Osborn DJ, Strain M, Gomelsky A, et. al. Obesity and female stress urinary incontinence. J Urol. 2013;82: 759.
Leiria LO, Sollon C, Bau FR, et. al. Insulin relaxes bladder via PI3K/AKT/eNOS pathway activation in mucosa: unfolded protein response-dependent insulin resistance as a cause of obesity-associated overactive bladder. J Physiol. 2013;591: 2259.
Subak LL, Wing R, West DS, et. al. Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med. 2009;360: 5.
Reeves GK, Pirie K, Beral V, et. al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ. 2007;335: 1134.
Renehan A, Roberts D, and Dive C. Obesity and cancer : pathophysiological and biological mechanisms. Arch Physiol Biochem. 2008; 114: 71.
Renehan AG, Frystyk J, and Flyvbjerg A. Obesity and cancer risk: the role of the insulin–IGF axis. Trends Endocrinol Metab. 2006;17: 328.
Renehan AG, Tyson M, Egger M, et. al. Body-mass index and incidence of cancer: a systematic review and metaanalysis of prospective observational studies. Lancet. 2008;371: 569.
Fischer-Posovszky P, Wabitsch M, and Hochberg Z. Endocrinology of adipose tissue—an update. Horm Metab Res. 2007;39: 314.
Vona-Davis L, and Rose DP. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer. 2007;14: 189.
Bray GA. The underlying basis for obesity: relationship to cancer. J Nutr. 2002;132: 3451.
Fasshauer M, Klein J, Neumann S, et. al. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2002;290: 1084.
Kahn BB, and Flier JS. Obesity and insulin resistance. J Clin Invest. 2000; 106: 473.
Allot E, Masko E, and Freedland S. Obesity and prostate cancer: weighing the evidence. Eur Urol. 2013;63: 800.
Banez LL, Hamilton RJ, Partin AW, et. al. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. JAMA. 2007;298: 2275.
Hekal I, and Ibrahiem E. Obesity-PSA relationship: a new formula. Prostate Cancer Prostatic Dis. 2010;13: 186.
Chu DI, De Nunzio C, Gerber L, et. al. Predictive value of digital rectal examination for prostate cancer detection is modified by obesity. Prostate Cancer Prostatic Dis. 2011;14: 346.
Siddiqui SA, Inman BA, Sengupta S, et. al. Obesity and survival after radical prostatectomy: a 10-year prospective cohort study. Cancer. 2006;107: 521.
Gong Z, Agalliu I, Lin DW, et. al. Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men. Cancer. 2007;109: 1192.
Renehan AG, Zwahlen M, Minder C, et. al. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet. 2004;363: 1346.
Schnoeller T, Jentzmik F, Rinnab L, et. al. Circulating free testosterone is an independent predictor of advanced disease in patients with clinically localized prostate cancer. World J Urol. 2013;31: 253.
Li H, Stampfer MJ, Mucci L, et. al. A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival. Clin Chem. 2010;56: 34.
Chow W, Gridley G, Fraumeni J, et. al. Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med. 2000; 343: 1305.
Bergstrom A, Hsieh C, Linblad P, et. al. Obesity and renal cell cancer-a quantitative review. Br J Cancer. 2001;85:984.
Stampfer MJ, Speizer FE, Willett WC, et. al. A prospective study of body mass index, hypertension, and smoking and the risk of renal cell carcinoma (United States). Cancer Causes Control. 2005;16: 1099.
Chromecki T, Cha E, Fajkovic H, et. al. Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy. BJUI. 2012;111: 249.
Lerro C, Mc Glynn K, and Cook M. A systematic review and meta-analysis of the relationship between body size and testicular cancer. Br J Cancer. 2010;103: 1467.
Barnes K, McDowell B, Button A, et. al. Obesity is associated with increased risk of invasive penile cancer. BMC Urol. 2016;16: 42.
Ladosky W, Botelho MA, and Albuquerque JP. Jr. Chest mechanics in morbidly obese non-hypoventilated patients. Respir Med. 2001;95: 281.
Littleton SW. Impact of obesity on respiratory function. Respirology. 2012;17: 43.
Damia G, Mascheroni D, Croci M, et. al. Perioperative changes in functional residual capacity in morbidly obese patients. Br J Anaesth. 1988;60: 574.
Alpert MA, and Hashimi MW. Obesity and the heart. Am J Med Sci. 1993;306: 117.
Lavie CJ, and Messerli FH. Cardiovascular adaptation to obesity and hypertension. Chest. 1986;90: 275.
Hussain Z, Gadd K, Curtain C, et. al. Anaesthetists’ drug dosing practices in class III obese surgical patients: a binational survey. Anaesth Intensive Care. 2019;47: 516.
Eley VA, Christensen R, Guy L, et. al. Perioperative blood pressure monitoring in patients with obesity. Anesth Analg. 2019;128: 484.
Baraka AS, Taha SK, Aouad MT, et. al. Preoxygenation: comparison of maximal breathing and tidal volume breathing techniques. Anesthesiology. 1999;91: 612.
Mushambi MC, Kinsella SM, Popat M, et. al. Obstetric Anaesthetists’ Association and Difficult Airway Society Guidelines for the Management of Difficult and Failed Tracheal Intubation in Obstetrics. Anaesthesia. 2015;70: 1286.
Timmermann A, Nickel EA, and Pühringer F. Second generation laryngeal masks: expanded indications. Anaesthesist. 2015;64: 7.
Pelosi P, Croci M, Calappi E, et. al. Prone positioning improves pulmonary function in obese patients during general anesthesia. Anesth Analg. 1996;83: 578.
Wu SD, Yilmaz M, Tamul PC, et. al. Awake endotracheal intubation and prone patient
self-positioning: anesthetic and positioning considerations during percutaneous nephrolithotomy in obese patients. J Endourol. 2009;23: 1599.
Isono S, Tanaka A, and Nishino T. Lateral position decreases collapsibility of the passive pharynx in patients with obstructive sleep apnea. Anesthesiology. 2002;97: 780.
Ikeya E, Taguchi J, Ohta K, et. al. Compartment syndrome of bilateral lower extremities following laparoscopic surgery of rectal cancer in lithotomy position: report of a case. Surg Today. 2006;36: 1122.
Dabi Y, Rouscoff Y, Anract J, et. al. Impact of body mass index on the oncological outcomes of patients treated with radical cystectomy for muscle-invasive bladder cancer. World J Urol. 2017;35: 229.
Faraj KS, Abdul-Muhsin HM, Rose KM, et. al. Robot assisted radical cystectomy vs open radical cystectomy: over 10 years of the Mayo Clinic experience. Urol Oncol. 2019;37:862.
Bagrodia A, Grover S, Srivastava A, et. al. Impact of body mass index on clinical and cost outcomes after radical cystectomy. BJU Int. 2009;104: 326.
Furrer MA, Schneider MP, Burkhard FC, et. al. Incidence and perioperative risk factors for early acute kidney injury after radical cystectomy and urinary diversion. Urol Oncol. 2018;36: 306.
Liu NW, Hackney JT, Gellhaus PT, et. al. Incidence and risk factors of parastomal hernia in patients undergoing radical cystectomy and ileal conduit diversion. J Urol. 2014;191: 1313.
Abufaraj M, Mari A, Mansy K, et. al. Obesity and its implications on oncological urological surgery. Curr Opin Urol. 2017;27: 446.
Sperling CD, Xia L, Berger IB, et. al. Obesity and 30-day outcomes following minimally invasive nephrectomy. J Urol. 2018;121: 104.
Trudeau V, Karakiewicz PI, Boehm K, et. al. The effect of obesity on perioperative outcomes following percutaneous nephrolithotomy. J Endourol. 2016;30: 864.
Zhou X, Sun X, Chen X, et. al. Effect of obesity on outcomes of percutaneous nephrolithotomy in renal stone management: a systematic review and meta-analysis. Urol Int. 2017;98: 382.
Inanloo SH, Yahyazadeh SR, Rashidi S, et. al. Feasibility and safety of ultrasonography guidance and flank position during percutaneous nephrolithotomy. J Urol. 2018; 200: 195.
Fleisher LA, Fleischmann KE, Auerbach AD, et. al. ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. JACC. 2014;64: 22.
Tsai A, and Schumann R. Morbid obesity and perioperative complications. Curr Opin Anaesthesiol. 2016;29: 103.
![Impact of obesity on prostate cancer detection and pathogenesis.[37] DRE, Digital rectal examination. E, estrogen. T, testosterone.](https://li01.tci-thaijo.org/public/journals/215/submission_251600_24787_coverImage_en_US.jpg)
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Naresuan Phayao Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
ผู้นิพนธ์ต้องรับผิดชอบข้อความในบทนิพนธ์ของตน มหาวิทยาลัยพะเยาไม่จำเป็นต้องเห็นด้วยกับบทความที่ตีพิมพ์เสมอไป ผู้สนใจสามารถคัดลอก และนำไปใช้ได้ แต่จะต้องขออนุมัติเจ้าของ และได้รับการอนุมัติเป็นลายลักษณ์อักษรก่อน พร้อมกับมีการอ้างอิงและกล่าวคำขอบคุณให้ถูกต้องด้วย
The authors are themselves responsible for their contents. Signed articles may not always reflect the opinion of University of Phayao. The articles can be reproduced and reprinted, provided that permission is given by the authors and acknowledgement must be given.
